Motokazu Sugimoto

ORCID: 0000-0002-1654-0613
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Pancreatitis Pathology and Treatment
  • Neuroendocrine Tumor Research Advances
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Nutrition and Health in Aging
  • Cancer Genomics and Diagnostics
  • Gallbladder and Bile Duct Disorders
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • MRI in cancer diagnosis
  • Colorectal Cancer Treatments and Studies
  • Frailty in Older Adults
  • Esophageal and GI Pathology
  • Peptidase Inhibition and Analysis
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Surgical Treatments
  • Metastasis and carcinoma case studies
  • Gastrointestinal disorders and treatments
  • Body Composition Measurement Techniques
  • Appendicitis Diagnosis and Management
  • Neuroblastoma Research and Treatments
  • Lung Cancer Diagnosis and Treatment
  • Surgical site infection prevention
  • Surgical Simulation and Training

National Cancer Center Hospital East
2015-2025

Nagaoka University
2024

Nagaoka University of Technology
2024

Eastern Hepatobiliary Surgery Hospital
2020

Second Military Medical University
2020

Mayo Clinic
2017-2019

WinnMed
2019

Mayo Clinic in Arizona
2018-2019

Center for Digestive and Liver Diseases
2018

UCLA Medical Center
2017

Purpose To develop and evaluate a fully automated algorithm for segmenting the abdomen from CT to quantify body composition. Materials Methods For this retrospective study, convolutional neural network based on U-Net architecture was trained perform abdominal segmentation data set of 2430 two-dimensional examinations tested 270 examinations. It further separate 2369 patients with hepatocellular carcinoma (HCC). were performed between 1997 2015. The mean age 67 years; male patients, it years...

10.1148/radiol.2018181432 article EN Radiology 2018-12-27
Thomas F. Stoop Toshitaka Sugawara Atsushi Oba Isabel M. Feld Stijn van Roessel and 95 more Eran van Veldhuisen Yan‐Dong Wu Jo Nishino Mahsoem Ali Adnan Alseidi Alain Sauvanet Antonino Mirabella António Sá Cunha Arto Kokkola Bas Groot Koerkamp Daniel Pietrasz Dyre Kleive Giovanni Butturini Giuseppe Malleo Hanneke W.M. van Laarhoven Isabella Frigerio J. Dembinski Jing He Johan Gagnière Jörg Kleeff José Manuel Ramia Keith Roberts Knut Jørgen Labori Marco V. Marino Massimo Falconi Michael Bau Mortensen Mickaël Lesurtel Morgan Bonds Nikolaos Chatzizacharias Oliver Strobel Olivıer Turrini Oonagh Griffin Oskar Franklin Per Pfeiffer Richard D. Schulick Roberto Salvia Roeland F. de Wilde Safi Dokmak Salvador Rodriguez Franco Simone Augustinus Stefan Kobbelgaard Burgdorf Stefano Crippa Thilo Hackert Timo Tarvainen William R. Burns Wells A. Messersmith Johanna W. Wilmink Richard A. Burkhart Marco Del Chiaro Marc G. Besselink Ajay N. Jain Akio Saiura Alberto Balduzzi Alejandro Serrablo Alessandro Coppola Alessandro Zerbi Ammar A. Javed Andrej Nikov Asif Halimi Attila Bursics Boris V. Janssen Braden N. Miller Alexis Laurent Claudia E. Mack Daisuke Hashimoto Damiano Caputo Elena Rangelova Elisabetta Sereni Felix Rückert Frederik Berrevoet Gianpaolo Balzano Giedrius Barauskas Giulio Belfiori Giuseppe Fusai Geert Kazemier Henrique Alexandrino Hirofumi Ishida Jacob L. van Dam Jean–Baptiste Bachet Julien Taı̈eb Keiichi Akahoshi Kevin C. Conlon Kimitaka Tanaka Kürşat Dikmen Lilian Schwartz Lysiane Marthey Martijn W.J. Stommel Martin Varga Michael G. House Minoru Tanabe Mohammed Al-Musawi Motokazu Sugimoto Naoto Gotohda Nicolas Régenet Olivier R. Busch

Importance The effect of adjuvant chemotherapy following resection pancreatic adenocarcinoma after preoperative (m)FOLFIRINOX (combination leucovorin calcium [folinic acid], fluorouracil, irinotecan hydrochloride, and oxaliplatin in full or modified dosing) on overall survival (OS) is unclear because current studies do not account for the number cycles regimen. Objective To investigate association with OS, taking into Design, Setting, Participants This retrospective cohort study included...

10.1001/jamaoncol.2024.5917 article EN JAMA Oncology 2025-01-23

Generally, cancer tissue is palpated as a hard mass. However, the elastic nature of not well understood. The aim present study was to evaluate clinical utility measuring modulus (EM) in colorectal tissue. Using tactile sensor, we measured EM 106 surgically resected tissues. Data on were compared with clinicopathological findings, including stromal features represented by Azan staining and α-SMA positive area ratio tumor area. Finally, cDNA microarray profile tumors high findings low EM. A...

10.1111/cas.12720 article EN cc-by-nc Cancer Science 2015-06-17

Postoperative pancreatic fistula (POPF) is a major, intractable complication after distal pancreatectomy (DP). Risk factor evaluation and prevention of this are important tasks for surgeons.One hundred six patients who underwent DP using stapler division were retrospectively investigated. The relationship between clinicopathological factors the incidence POPF was statistically analyzed.Clinically relevant, Grade B or C by International Study Group Pancreatic Fistula criteria occurred in 52...

10.1007/s00534-013-0596-0 article EN Journal of Hepato-Biliary-Pancreatic Sciences 2013-02-21

Importance Preoperative chemo(radio)therapy is increasingly used in patients with localized pancreatic adenocarcinoma, leading to pathological complete response (pCR) a small subset of patients. However, multicenter studies in-depth data about pCR are lacking. Objective To investigate the incidence, outcome, and risk factors after preoperative chemo(radio)therapy. Design, Setting, Participants This observational, international, cohort study assessed all consecutive pathology-proven...

10.1001/jamanetworkopen.2024.17625 article EN cc-by-nc-nd JAMA Network Open 2024-06-18

We successfully determined the difference of immune microenvironments between pNENs and pancreatic ductal adenocarcinomas (PDACs), histology-dependent variability among using multispectral fluorescent imaging system. Tumour tissue samples including 52 18 PDACs were investigated. The tumour-infiltrating lymphocytes (TILs), their PD-1 PD-L1 expression in comprehensively quantitatively analysed subsequently compared with those PDACs. A principal component analysis revealed that profile is...

10.1038/s41598-018-31383-9 article EN cc-by Scientific Reports 2018-08-28

According to the 2012 International Consensus Guidelines, diagnostic criterion of intraductal papillary mucinous neoplasms (IPMNs) involving main duct (MD IPMNs) or and branch ducts (mixed pancreatic system is a (MPD) diameter 5.0 mm greater on computed tomography (CT) magnetic resonance imaging (MRI). However, surgical resection recommended for patients with an MPD 10.0 greater, which characterized as high-risk stigma. An 9.0 not indication immediate resection.To determine appropriate...

10.1001/jamasurg.2016.3349 article EN JAMA Surgery 2016-11-09

Abstract Background and Objectives Conclusive evidence in favor of neoadjuvant therapy for those with non‐metastatic pancreatic ductal adenocarcinoma (PDAC) is still lacking. The objective this study was to evaluate the survival benefit vs upfront surgery patients PDAC. Methods involved 565 undergoing or as primary treatment Propensity score matching performed between group (NAT group) (UFS using 20 clinical variables at diagnosis. Overall surgical pathology were compared two groups on an...

10.1002/jso.25681 article EN Journal of Surgical Oncology 2019-08-26

There is no established postoperative adjuvant therapy for hepatocellular carcinoma (HCC), and improvement of patient prognosis has been limited. We conducted long-term monitoring patients within a phase II trial that targeted cancer antigen, glypican-3 (GPC3), specifically expressed in HCC. sought to determine if the GPC3 peptide vaccine was an effective by disease-free survival overall survival. also tracked immunohistochemical (IHC) staining, CTL induction, plasma group administered (n =...

10.1111/cas.14497 article EN cc-by-nc Cancer Science 2020-05-25

Pancreatic cancer is associated with development of cachexia, a wasting syndrome thought to limit survival. Few studies have longitudinally quantified peripheral tissues or identified biomarkers predictive future tissue wasting.Adipose and muscle were measured by computed tomography (CT) at diagnosis 50 120 days later in 164 patients advanced pancreatic cancer. Tissue changes survival evaluated Cox proportional hazards regression. Baseline levels circulating markers examined relation...

10.1158/1055-9965.epi-19-0370 article EN Cancer Epidemiology Biomarkers & Prevention 2019-09-18

Abstract Sarcomatoid hepatocellular carcinoma (SHCC), which was a rare histological subtype of (HCC), is currently subclassified as poorly differentiated HCC because insufficient evidence to define SHCC HCC. We aimed assess the feasibility classifying by comprehensively identifying novel and distinct characteristics compared ordinary (OHCC). Fifteen SHCCs (1.4%) defined with at least 10% sarcomatous component, 15 randomly disease‐stage‐matched OHCCs 163 consecutive were extracted from 1106...

10.1002/ijc.33545 article EN International Journal of Cancer 2021-03-04
Coming Soon ...